INX-P

• UNSPSC Description:

  INX-P is glucocorticosteroid-target antibody drug conjugate (ADC)[1].

• Target Antigen:

  ADC Linker; Glucocorticoid Receptor

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related;Immunology/Inflammation;Vitamin D Related/Nuclear Receptor

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/inx-p.html

• Solubility:

  10 mM in DMSO

• Smiles:

  BrCC(NCC(N[C@@H](CCC(O)=O)C(NC(C1)(C2)CC12CC3=CC=C([C@H]4O[C@@]5([C@](C[C@]6([H])[C@@]5(C[C@@H]([C@@]7([H])[C@@]6([H])CCC([C@@]7(C=C8)C)=CC8=O)O)C)([H])O4)C(CO)=O)C=C3)=O)=O)=O

• Molecular Weight:

  866.79

• References & Citations:

  [1]Jay ROTHSTEIN, et al. NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOF. WO2022150637A1

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2734878-02-3